United Kingdom-London: Effectiveness and pharmacoepidemiology studies EMA/2014/50/RE

'Post-authorisation effectiveness and pharmacoepidemiology research to generate data and information to support regulatory decision-making. Research may also focus on the effectiveness of regulatory measures taken and on the impact of relevant legislation. The range of topics is limited to those with high public health relevance and with a European impact. The scope of the funding covers both nationally and centrally authorised products, including vaccines. EMA supports the conduct of this research in line with the principles and tools for scientific independence, transparency and sound methods of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). The re…

Read all of it on Contracts Finder →